3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.
3T Biosciences was founded in 2017 by Leah Sibener, Luke Lee, Marvin Gee.
1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 43 based in San Francisco Bay Area.
3T Biosciences may be growing as evidenced by recent strategic deals that have significantly increased their potential revenue. The company has inked a second T-cell anticancer deal with Boehringer, which could lead to a potential payday of $538.5 million. Additionally, 3T Biosciences has been part of deals with a combined value of $2.5 billion, indicating a substantial influx of funding and investment into the company. These deals are indicative of an expansion in operations and a strong vote of confidence from industry partners.
“We are solving a major bottleneck in the field of targeted biotherapeutics in oncology – the identification of novel targets for the treatment of solid tumors.” 3tbiosciences.com
3T Biosciences has a 11-50 person team and operates in biopharma, listed under San Francisco Bay Area, and has been around since 2017. Its website drew about 1,049 visits in the latest month measured and its founders are Leah Sibener, Luke Lee and Marvin Gee.
11-50 employees · alxoncology.com
11-50 employees · acernatec.com
11-50 employees · a-biodesign.com
101-250 employees · adicetbio.com
1-10 employees · 20visioneers15.com
501-1,000 employees · adaptimmune.com
501-1,000 employees · apcerls.com
11-50 employees · 89bio.com
11-50 employees · abalonebio.com
11-50 employees · ab-biotics.com
Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.